Discovering how to identify new psychoactive substances through PhD research Researcher Amira Guirguis is designing a model to improve on-site identification of new psychoactive substances of misuse. She explains why the work is vital to reduce unnecessary hospital admissions and prevent avoidable deaths.…
Top 10 news stories of 2014 from The Pharmaceutical Journal Harriet Adcock provides a rundown of the top ten news stories of 2014.…
Plans to name pharmacies in patient safety incident reports postponed NHS England has postponed plans for community pharmacists to name their pharmacy when they report patient safety incidents until after the law is changed to decriminalise dispensing errors.…
Government advisory board members concerned about removal of anonymity for error reportsCommunity pharmacists in England may face an increased risk of prosecution for a dispensing error because of changes made to their national contract, according to some members of a government advisory board.…
Pfizer offers settlement in class action over Parkinson’s drug CabaserCompany has offered to settle a class action brought by more than 150 patients in Australia who allege they were never warned about the side effects of treatment.…
Uruguay delays plans to sell cannabis in pharmacies Marijuana will not be sold in pharmacies in Uruguay until March 2015, the National Drugs Board (JND) has announced.…
Q&A: Pharmacy regulation and the law Lawyer Noel Wardle, a partner at Charles Russell Speechlys, which specialises in business law, talks about UK pharmacy regulation and the threat of pharmacists facing prosecution for dispensing errors.…
Medicinal cannabis: time for a comeback? The stringent laws on cannabis do no favours for patients, clinicians and researchers.…
UK bill aims to allow off-patent drugs to be licensed for new purposes A bill going through Parliament wants the National Institute for Health and Care Excellence (NICE) to appraise off-patent drugs to allow them to be used for new indications.…
Review of fitness-to-practise cases suggests pharmacy regulator acts fairly Pharmacists are likely to be dealt with fairly if they find themselves up before the professional regulator’s fitness-to-practise committee, according to published research.…